Company news
Beijing Scitop Bio-tech Co., Ltd. Class A (SZSE:300858) news
Beijing Scitop Bio-tech Co., Ltd. Class A news releases on 6ix. Latest, Apr 22, 2026: Beijing Scitop Bio-tech Co: Revenue up 20.85%, net profit stable…
Press releases & updates
Beijing Scitop Bio-tech Co: Revenue up 20.85%, net profit stable, probiotics and microecological agents drive growth
April 21, 2026
Beijing Scitop Bio-tech Co: Q3 2025 saw strong revenue and profit growth, with major R&D and capacity investments
October 21, 2025
Beijing Scitop Bio-tech Co: Revenue up 18.32% YoY, net profit down 5.31% amid capacity investment and strong microecological growth
August 20, 2025
Beijing Scitop Bio-tech Co: Probiotics led strong growth, offsetting declines in food additives, with robust cash flow and R&D
April 22, 2025
Beijing Scitop Bio-tech Co: Revenue up, net profit slightly down, with improved cash flow and higher management expenses
October 29, 2024
Beijing Scitop Bio-tech Co: Net profit grew 7.89% year-over-year on strong probiotics and microecological product sales
August 21, 2024